Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant-PA: INMD Start Up Funds (bridge funding) - New Investigators

McMaster University

$100,000.00

NOD2 immunity protects against obesity-induced inflammation and insulin resistance

EF 2011-12

Résumé
The rise in type 2 diabetes is alarming and preceded by a period of where the body cannot properly respond to insulin. This insulin resistance can last for many years and provides a window of opportunity to prevent the onset of overt diabetes. Approximately 50% of adult Canadians are overweight and obesity is the most significant factor that contributes to insulin resistance. Obesity is associated with a chronic state of inflammation, which is critical in causing insulin resistance. Major efforts are focussed on determining how increased inflammation causes insulin resistance. However, our immune system may also protect against insulin resistance. We have discovered that a particular part of the immune system, which detects a specific part of bacteria, is important in preventing excessive obesity and insulin resistance. The absence of this immune component, called NOD2, brings about a series of changes starting with the bacteria that live in our gut, progressing to the liver and fat, which ultimately worsens whole body insulin resistance. The objective of this research is to understand how NOD2-mediated immunity protects against insulin resistance. Understanding this will help develop therapies to combat diabetes. This also has added benefit of being relevant to specific patient populations since defects in NOD2 are the major predictor of chronic gut inflammatory pathologies such as Crohn's disease. This work may direct novel nutritional interventions with specific probiotics and may identify new therapies that could prevent type 2 diabetes. It may also direct changes in the monitoring or care of patients with inflammatory gut diseases and diabetes.
Programme
Operating Grant-PA: INMD Start Up Funds (bridge funding) - New Investigators
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
259504
Name
Schertzer Jonathan D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
NOD2 immunity protects against obesity-induced inflammation and insulin resistance
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant-PA: INMD Start Up Funds (bridge funding) - New Investigators
Keyworddelim
Cell Biology; Diabetes; Glucose; Gut Bacteria; Immunity; Inflammation; Insulin; Metabolic Disease; Obesity; Physiology
Abstract
The rise in type 2 diabetes is alarming and preceded by a period of where the body cannot properly respond to insulin. This insulin resistance can last for many years and provides a window of opportunity to prevent the onset of overt diabetes. Approximately 50% of adult Canadians are overweight and obesity is the most significant factor that contributes to insulin resistance. Obesity is associated with a chronic state of inflammation, which is critical in causing insulin resistance. Major efforts are focussed on determining how increased inflammation causes insulin resistance. However, our immune system may also protect against insulin resistance. We have discovered that a particular part of the immune system, which detects a specific part of bacteria, is important in preventing excessive obesity and insulin resistance. The absence of this immune component, called NOD2, brings about a series of changes starting with the bacteria that live in our gut, progressing to the liver and fat, which ultimately worsens whole body insulin resistance. The objective of this research is to understand how NOD2-mediated immunity protects against insulin resistance. Understanding this will help develop therapies to combat diabetes. This also has added benefit of being relevant to specific patient populations since defects in NOD2 are the major predictor of chronic gut inflammatory pathologies such as Crohn's disease. This work may direct novel nutritional interventions with specific probiotics and may identify new therapies that could prevent type 2 diabetes. It may also direct changes in the monitoring or care of patients with inflammatory gut diseases and diabetes.
Competitiondate
201203
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schertzer, Jonathan D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~